EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Performance of the WID ‐ qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana

Sebastian Ken-Amoah iD, Elisa Redl iD, Bright K S Domson, James E Barrett iD, Lena Schreiberhuber iD, Chiara Herzog iD, Rupali Arora, Allison Jones, Iona Evans, Dan Reisel, Esther Lamptey-Mills, Vincent B Nachinab und 5 weitere

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35260 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Sebastian Ken-Amoah und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University of Cape Coast, Cape Coast, Ghana. Hauptthemen laut MEDLINE: Uterine Hemorrhage, DNA Methylation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Samira Empowerment and Humanitarian Projects, University College London Global Engagement Fund, The Land Tirol (EUTOPS Institute).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The burden of uterine cancer is growing and, in the US and UK, mortality rates are poorest among black women. Early detection of these cancers is critical and poor performance of ultrasound in black women may contribute to adverse outcomes. Limited data on this topic are available from Africa. We assessed whether a simple DNA methylation test, the WID‐qEC, enables detection of all epithelial uterine (endometrial and cervical) cancers in women presenting with abnormal uterine bleeding (AUB) in Ghana. Among 118 women ≥40 years presenting with AUB, 106 consented to the study and a cervicovaginal sample was obtained for WID‐qEC testing. Subsequent to ultrasound assessment 102 women had a cervical or endometrial biopsy. Histopathology, ultrasound and WID‐qEC testing were analyzed and compared. Among the 102 volunteers, 8 and 15 were diagnosed with endometrial and cervical cancer (EC and CC), respectively. The receiver operating characteristic (ROC) area under the curve (AUC) was 0.56 (95% confidence interval [CI] 0.25–0.86) for sonographic endometrial thickness (ET) and 0.98 (95% CI 0.94–1.00) for the WID‐qEC test. Sensitivity and specificity of the prespecified ET ≥5 mm were 66.7% (95% CI 24.1–94.0) and 22.7 (95% CI 12.0–38.2) and for the prespecified WID‐qEC SUM‐PMR ≥ 0.3 were 100% (95% CI 56.1–100.0) and 76.1 (96%CI 60.9–86.9), respectively. In addition, 15 CCs were detected by the WID‐qEC test [sensitivity 100% (95% CI 74.7–100.0)]. The WID‐qEC test accurately detects both EC and CC in black women presenting with AUB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine HemorrhageDNA MethylationHumansFemaleGhanaMiddle AgedProspective StudiesAdultEndometrial NeoplasmsUterine NeoplasmsBlack PeopleUterine Cervical NeoplasmsEarly Detection of CancerAgedUltrasonographyROC CurveSensitivity and SpecificityEndometrium

Stichwörter der Autor:innen

DNA methylationabnormal bleedingblack womenendometrial cancerultrasound

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, University of Cape Coast, Cape Coast, Ghana.
  • European Translational Oncology Prevention and Screening (EUTOPS) Institute, Hall in Tirol, Austria.
  • Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria.
  • Department of Microbiology and Immunology, University of Cape Coast, Cape Coast, Ghana.
  • Department of Pathology, University College London, London, UK.
  • Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.

ORCID-Profile: Sebastian Ken-Amoah, Elisa Redl, James E Barrett, Lena Schreiberhuber, Chiara Herzog, Martin Widschwendter

Förderung

  • Samira Empowerment and Humanitarian Projects
  • University College London Global Engagement Fund
  • The Land Tirol (EUTOPS Institute)
  • The Eve Appeal

Zitieren

APA

Ken-Amoah, S., Redl, E., Domson, B. K. S., Barrett, J. E., Schreiberhuber, L., Herzog, C., Arora, R., Jones, A., Evans, I., Reisel, D., Lamptey-Mills, E., Nachinab, V. B., Pepera, T., Olaitan, A., Obiri-Yeboah, D., Akakpo, P. K., & Widschwendter, M. (2025). Performance of the WID ‐ qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana. International Journal of Cancer. https://doi.org/10.1002/ijc.35260

Vancouver

Ken-Amoah S, Redl E, Domson BKS, Barrett JE, Schreiberhuber L, Herzog C, et al. Performance of the WID ‐ qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana. International Journal of Cancer. 2025. doi:10.1002/ijc.35260

BibTeX
@article{KenAmoah2025,
  author = {Ken-Amoah, Sebastian and Redl, Elisa and Domson, Bright K S and Barrett, James E and Schreiberhuber, Lena and Herzog, Chiara and Arora, Rupali and Jones, Allison and Evans, Iona and Reisel, Dan and Lamptey-Mills, Esther and Nachinab, Vincent B and Pepera, Theodora and Olaitan, Adeola and Obiri-Yeboah, Dorcas and Akakpo, Patrick K and Widschwendter, Martin},
  title = {Performance of the WID ‐ qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35260}
}
Kostenlos starten →